Amgen Inc. completed the acquisition of Horizon Therapeutics, becoming a wholly-owned subsidiary of Amgen, with a cash consideration of approximately $26.7 billion.
AI Assistant
AMGEN INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.